APA (7th ed.) Citation

McCarty, K. L., Watt, T., Dan, T. D., Timmerman, R. D., & Kumar, K. A. (2025). Use of PULSAR (personalized ultra-fractionated stereotactic adaptive radiotherapy) as consolidation with immune checkpoint inhibition in the treatment of pediatric metastatic melanoma. Radiation Oncology, 20(1), 1. https://doi.org/10.1186/s13014-025-02691-y

Chicago Style (17th ed.) Citation

McCarty, Kyra L., Tanya Watt, Tu D. Dan, Robert D. Timmerman, and Kiran A. Kumar. "Use of PULSAR (personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy) as Consolidation with Immune Checkpoint Inhibition in the Treatment of Pediatric Metastatic Melanoma." Radiation Oncology 20, no. 1 (2025): 1. https://doi.org/10.1186/s13014-025-02691-y.

MLA (9th ed.) Citation

McCarty, Kyra L., et al. "Use of PULSAR (personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy) as Consolidation with Immune Checkpoint Inhibition in the Treatment of Pediatric Metastatic Melanoma." Radiation Oncology, vol. 20, no. 1, 2025, p. 1, https://doi.org/10.1186/s13014-025-02691-y.